Merck & Co (NYSE: MRK)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $108.18
-
Support level$100.93
-
Resistance levelN/A
-
Beta0.2
-
RSI (14-day)54.8
- MRK is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- The price of this low-beta stock is expected to increase by 0.2 percent for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $73.47 | $111.11 | 93.5% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $87.12 | $102.78 | $108.51 | $109.67 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.0%
-
In the next month13.0%
-
In the next year57.7%
| Period | Value |
|---|---|
| Historical (5 year) | 23.0% |
| Last month | 31.2% |
| Current estimate | 22.1% |
| Next month forecast | 22.9% |